82 results on '"Wo, J.Y."'
Search Results
2. NRG Oncology International Consensus Atlas on Target Volumes for Dose-Escalated Pancreatic Cancer Radiotherapy
3. Five-Year Outcomes of a Phase II Study of Post-Operative Proton Beam Radiation for Gynecologic Cancers
4. Long-Term Outcomes of Definitive Chemoradiation with Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials
5. Rates of Hepatotoxicity Following Liver-Directed Ablative External Beam Radiotherapy and Transarterial Radioembolization for Hepatocellular Carcinoma
6. Proton Re-Irradiation for Esophageal Cancer: A Single-Institution Retrospective Series
7. Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade
8. Radiation-Associated Lymphopenia in Advanced Prostate Cancer Treated with Contemporary Radiation Techniques
9. Molecular Mechanisms of Intratumoral Nerve Recruitment and Perineural Invasion Elucidated with Spatial Transcriptomics and CRISPR Activation
10. Intercellular Mechanisms of Therapeutic Resistance at the Tumor-Stromal Interface Using Ultra High-Plex Single-Cell Spatial Transcriptomics and Genetically-Engineered Tumoroids
11. Knowledge and Understanding of Treatment Options among Patients with Gastrointestinal (GI) Cancer in an Academic Cancer Center
12. High Baseline TNF-α Levels may Associate with Poor Outcomes after Total Neoadjuvant Therapy for Gastroesophageal Cancer: Initial Biomarker Analysis from a Prospective Study
13. Long-Term Results of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Irradiation of Unresectable Primary Liver Tumors
14. Prediction of Hepatic Toxicity after Radiotherapy Using a Neural Network Including Blood Biomarkers and Liver Dose Distributions
15. Prediction of Outcomes after Radiotherapy for Hepatocellular Carcinoma Independently Validated Using Multi-Institutional Data
16. The Evolving Landscape of Treatment Paradigms for Locally Advanced Rectal Cancer: A Survey Study of Gastrointestinal Radiation Oncology Experts
17. Phase Ib Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
18. Clinical Correlates of Portal Venous or Superior Mesenteric Vein Thrombosis Following Neoadjuvant Therapy with Dose Escalated Radiation for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
19. Long Term Risk of Pelvic Insufficiency Fractures and Lower Extremity Edema After Definitive Chemoradiation for Squamous Cell Carcinoma of the Anal Canal
20. Mixed Methods Evaluation of a Targeted One-Week Virtual Radiation Oncology Intensive Shadowing Experience for Medical Students Underrepresented in Medicine: Mentor's Perspective
21. Effect of Mismatch Repair Status on Outcome of Early Stage Grade 1-2 Endometrial Cancer Treated With Vaginal Brachytherapy
22. Gender Disparities in Philanthropic Fundraising by Academic Oncologists
23. Long Term Follow-up of a Phase II Study of Autophagy Inhibition with Hydroxychloroquine (HCQ) and Preoperative (Preop) Short Course Chemoradiation (SCRT) Followed by Early Surgery for Resectable Ductal Adenocarcinoma of the Head of Pancreas (PDAC)
24. Longitudinal Follow-up of Women who received Pelvic Radiation for Lower GI or Gynecologic Cancers
25. Evaluating the Impact of Combination of Nivolumab and Ipilimumab to Liver/Lung SBRT on Local Control for Colorectal and Pancreatic Cancer: A Pooled Analysis of Two Prospective Trials
26. A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA
27. Dosimetric Analysis and NTCP Model for Child-Pugh Score and ALBI Increase after Hepatic Irradiation
28. Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-Adjusted Analysis
29. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma
30. Local Therapy for a Systemic Disease: Indications and Impact of Radiation Therapy to the Pancreatic Primary in Metastatic Pancreatic Cancer
31. Proton Therapy and the Role of Dosimetric Parameters as Predictors for Normal Tissue Complications after Liver-Directed Stereotactic Body Radiation Therapy
32. Patterns of Failure and Need for Biliary Intervention among Patients with Biliary Tract Cancers Treated with Definitive Surgery and Adjuvant Chemoradiation
33. Association of Dosimetric and Treatment Related Factors with Radiation Induced Lymphopenia and Overall Survival among Patients Treated in the FOLFIRINOX Era
34. The Immune Milieu of Anal Squamous Cell Carcinoma: IDO Expression is Correlated with Poor Outcome
35. Cost-Effectiveness of Short Course Radiation Therapy Versus Long-Course Chemoradiation for Locally Advanced Rectal Adenocarcinoma
36. Circulating Tumor DNA to Predict Surgical Outcome after Neoadjuvant Chemoradiation for Borderline Resectable/Locally Advanced Pancreatic Cancer
37. A Pilot Feasibility Study of Definitive Concurrent Chemoradiation with Pencil Beam Scanning Proton Beam in Combination with 5-fluorouracil and Mitomycin-c for Carcinoma of the Anal Canal
38. End-of-Life Care for Patients with Potentially Resectable Pancreatic Cancer Who Received Radiation Therapy
39. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
40. Safety and Tolerability of Liver Re-Irradiation
41. Hepatocyte Growth Factor is Associated With Liver Dysfunction and Survival: Biomarker Results of a Phase 2 Study of Proton Beam Therapy in Patients with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
42. Genomic Evolution and Acquired Resistance to Pre-Operative Chemoradiation Therapy in Locally Advanced Rectal Cancer
43. Sexual Function, Quality of Life (QOL), and Mood After Radiation Therapy in Patients With Anal Cancer
44. Clinical Needs Assessment for Sexual Health Among Cancer Patients Receiving Pelvic Radiation
45. Elective Nodal Irradiation With Simultaneous Integrated Boost Stereotactic Body Radiation Therapy for Pancreatic Cancer
46. Intraoperative Radiation Therapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiation Therapy for Pancreatic Adenocarcinoma
47. Irradiation of Anatomically Defined Pelvic Bone Marrow Subsites and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation
48. Change in Platelet Count and Normal Liver Dosimetry in Patients Receiving Proton Radiation Therapy for Unresectable Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
49. Long-Term Outcomes and Toxicity of Anal Cancer Patients Treated Per Radiation Therapy Oncology Group 0529
50. Treatment-Induced Changes in Circulating Lymphocyte Populations Associate With Survival of Patients With Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC) Treated With Hypofractionated Proton Therapy (HPT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.